MedTrace Logo

Trancutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations

NCT01815034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2014-08-19

No results posted yet for this study

Summary

Use of trancutaneous CO2 (TC02) monitoring to aide in titration of sedation of midazolam and fentanyl. Trancutaneous readings validated with invasively obtained specimens from existing arterial sheaths required during AF and VT ablations (trans-septal and retrograde aortic respectively)

Conditions

  • Hypercapnia

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Daniel J Cantillon, MD · The Cleveland Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01815034 on ClinicalTrials.gov